Please enable JavaScript to continue using this application.

Compare $KRRO vs $VYGR | Chartloom

Compare

$KRRO vs $VYGR

Korro Bio Inc · Voyager Therapeutics Inc

KRRO

Korro Bio Inc

VYGR

Voyager Therapeutics Inc

Compare $KRRO vs $VYGR

Comparing Korro Bio Inc and Voyager Therapeutics Inc

KRROKorro Bio Inc

VYGRVoyager Therapeutics Inc

KRROKorro Bio Inc

Market cap

$147M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

143.63x

Rev growth (TTM)

-62.1%

YTD performance

26.2%

52W performance

-77.8%

FCF yield

-46.6%

VYGRVoyager Therapeutics Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.33x

Rev growth (TTM)

-19.1%

YTD performance

-39.2%

52W performance

-53.6%

FCF yield

-82.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KRRO

VYGR

Detailed metrics comparison

KRRO

Korro Bio Inc

VYGR

Voyager Therapeutics Inc

Market Cap

KRRO$147M

VYGR$148M

Enterprise Value

KRRO$122M

VYGR$112M

Price

KRRO$10.16

VYGR$2.45

P/E Ratio

KRRON/A

VYGRN/A

P/S Ratio

KRRO61.51x

VYGR4.30x

EV/Sales

KRRO51.05x

VYGR3.26x

EV/EBITDA

KRRO0.00x

VYGR8.61x

P/B Ratio

KRRO1.38x

VYGR1.01x

P/FCF Ratio

KRRON/A

VYGRN/A

EV/FCF

KRRO-1.78x

VYGR-0.92x

PEG Ratio

KRRON/A

VYGRN/A

Forward P/E (NTM)

KRRON/A

VYGRN/A

Forward P/S (NTM)

KRRO143.63x

VYGR5.33x

Revenue (TTM)

KRRO$2M

VYGR$34M

Revenue Growth (YoY)

KRRO-62.1%

VYGR-19.1%

Forward Rev Growth

KRRO240.0%

VYGR129.7%

Gross Margin (TTM)

KRRO0.0%

VYGR0.0%

Operating Margin (TTM)

KRRO0.0%

VYGR0.0%

EBITDA Margin (TTM)

KRRO-3068.6%

VYGR-329.0%

Net Margin (TTM)

KRRO-4477.1%

VYGR-312.6%

FCF Margin (TTM)

KRRO-2865.9%

VYGR-352.4%

Net Income (TTM)

KRRO$-107M

VYGR$-108M

FCF (TTM)

KRRO$-68M

VYGR$-121M

EPS (TTM)

KRRO-$6.05

VYGR-$1.78

ROE (TTM)

KRRO-11426.0%

VYGR-5792.0%

ROA (TTM)

KRRO-6857.0%

VYGR-4500.0%

ROIC (TTM)

KRRO-11426.0%

VYGR-5792.0%

Cash

KRRO$25M

VYGR$36M

Debt

KRRO$0

VYGR$0

Net Cash/Debt

KRRO$25M

VYGR$36M

Current Ratio (TTM)

KRRO9.55x

VYGR7.51x

Quick Ratio (TTM)

KRRO9.11x

VYGR7.16x

Debt/Equity (TTM)

KRRO0.00x

VYGR0.00x

Debt/Assets (TTM)

KRRO0.0%

VYGR0.0%

Interest Coverage (TTM)

KRRON/A

VYGRN/A

Net Debt/EBITDA (TTM)

KRRO0.00x

VYGR0.00x

Beta

KRRO3.27

VYGR1.11

52W Performance

KRRO-77.8%

VYGR-53.6%

YTD Performance

KRRO26.2%

VYGR-39.2%

% from 52W High

KRRO-81.8%

VYGR-55.9%

% from 52W Low

KRRO95.2%

VYGR5.2%

Asset Turnover (TTM)

KRRO0.04x

VYGR0.14x

FCF Yield (TTM)

KRRO-46.6%

VYGR-82.0%

Earnings Yield (TTM)

KRRO-72.8%

VYGR-72.8%

Dividend Yield (TTM)

KRRON/A

VYGRN/A

Rule of 40

KRRO-2,927.9

VYGR-371.4

EV/GP/RG

KRRON/A

VYGRN/A

Ticker research

View KRRO research View VYGR research

Metric	KRRO Korro Bio Inc	VYGR Voyager Therapeutics Inc
Market & Valuation
Market Cap	$147M	$148M
Enterprise Value	$122M	$112M
Price	$10.16	$2.45
P/E Ratio	N/A	N/A
P/S Ratio	61.51x	4.30x
EV/Sales	51.05x	3.26x
EV/EBITDA	0.00x	8.61x
P/B Ratio	1.38x	1.01x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.78x	-0.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	143.63x	5.33x
Revenue & Growth
Revenue (TTM)	$2M	$34M
Revenue Growth (YoY)	-62.1%	-19.1%
Forward Rev Growth	240.0%	129.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3068.6%	-329.0%
Net Margin (TTM)	-4477.1%	-312.6%
FCF Margin (TTM)	-2865.9%	-352.4%
Net Income (TTM)	$-107M	$-108M
FCF (TTM)	$-68M	$-121M
EPS (TTM)	-$6.05	-$1.78
ROE (TTM)	-11426.0%	-5792.0%
ROA (TTM)	-6857.0%	-4500.0%
ROIC (TTM)	-11426.0%	-5792.0%
Financial Health
Cash	$25M	$36M
Debt	$0	$0
Net Cash/Debt	$25M	$36M
Current Ratio (TTM)	9.55x	7.51x
Quick Ratio (TTM)	9.11x	7.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.27	1.11
52W Performance	-77.8%	-53.6%
YTD Performance	26.2%	-39.2%
% from 52W High	-81.8%	-55.9%
% from 52W Low	95.2%	5.2%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.14x
FCF Yield (TTM)	-46.6%	-82.0%
Earnings Yield (TTM)	-72.8%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,927.9	-371.4
EV/GP/RG	N/A	N/A
Ticker research	View KRRO research	View VYGR research

Valuation

P/S Ratio

VYGR

4.30x

KRRO

61.51x

EV/FCF

KRRO

-1.78x

VYGR

-0.92x

Growth & revenue

Revenue Growth TTM

VYGR

-19.1%

KRRO

-62.1%

Forward Revenue Growth

KRRO

240.0%

VYGR

129.7%

Profitability & performance

Gross Margin

KRRO

0.0%

VYGR

0.0%

ROE

VYGR

-5792.0%

KRRO

-11426.0%

FCF Yield %

KRRO

-46.6%

VYGR

-82.0%

52-Week Performance

VYGR

-53.6%

KRRO

-77.8%

Detailed metrics comparison

KRRO

Korro Bio Inc

VYGR

Voyager Therapeutics Inc

Market Cap

KRRO$147M

VYGR$148M

Enterprise Value

KRRO$122M

VYGR$112M

Price

KRRO$10.16

VYGR$2.45

P/E Ratio

KRRON/A

VYGRN/A

P/S Ratio

KRRO61.51x

VYGR4.30x

EV/Sales

KRRO51.05x

VYGR3.26x

EV/EBITDA

KRRO0.00x

VYGR8.61x

P/B Ratio

KRRO1.38x

VYGR1.01x

P/FCF Ratio

KRRON/A

VYGRN/A

EV/FCF

KRRO-1.78x

VYGR-0.92x

PEG Ratio

KRRON/A

VYGRN/A

Forward P/E (NTM)

KRRON/A

VYGRN/A

Forward P/S (NTM)

KRRO143.63x

VYGR5.33x

Revenue (TTM)

KRRO$2M

VYGR$34M

Revenue Growth (YoY)

KRRO-62.1%

VYGR-19.1%

Forward Rev Growth

KRRO240.0%

VYGR129.7%

Gross Margin (TTM)

KRRO0.0%

VYGR0.0%

Operating Margin (TTM)

KRRO0.0%

VYGR0.0%

EBITDA Margin (TTM)

KRRO-3068.6%

VYGR-329.0%

Net Margin (TTM)

KRRO-4477.1%

VYGR-312.6%

FCF Margin (TTM)

KRRO-2865.9%

VYGR-352.4%

Net Income (TTM)

KRRO$-107M

VYGR$-108M

FCF (TTM)

KRRO$-68M

VYGR$-121M

EPS (TTM)

KRRO-$6.05

VYGR-$1.78

ROE (TTM)

KRRO-11426.0%

VYGR-5792.0%

ROA (TTM)

KRRO-6857.0%

VYGR-4500.0%

ROIC (TTM)

KRRO-11426.0%

VYGR-5792.0%

Cash

KRRO$25M

VYGR$36M

Debt

KRRO$0

VYGR$0

Net Cash/Debt

KRRO$25M

VYGR$36M

Current Ratio (TTM)

KRRO9.55x

VYGR7.51x

Quick Ratio (TTM)

KRRO9.11x

VYGR7.16x

Debt/Equity (TTM)

KRRO0.00x

VYGR0.00x

Debt/Assets (TTM)

KRRO0.0%

VYGR0.0%

Interest Coverage (TTM)

KRRON/A

VYGRN/A

Net Debt/EBITDA (TTM)

KRRO0.00x

VYGR0.00x

Beta

KRRO3.27

VYGR1.11

52W Performance

KRRO-77.8%

VYGR-53.6%

YTD Performance

KRRO26.2%

VYGR-39.2%

% from 52W High

KRRO-81.8%

VYGR-55.9%

% from 52W Low

KRRO95.2%

VYGR5.2%

Asset Turnover (TTM)

KRRO0.04x

VYGR0.14x

FCF Yield (TTM)

KRRO-46.6%

VYGR-82.0%

Earnings Yield (TTM)

KRRO-72.8%

VYGR-72.8%

Dividend Yield (TTM)

KRRON/A

VYGRN/A

Rule of 40

KRRO-2,927.9

VYGR-371.4

EV/GP/RG

KRRON/A

VYGRN/A

Ticker research

View KRRO research View VYGR research

Metric	KRRO Korro Bio Inc	VYGR Voyager Therapeutics Inc
Market & Valuation
Market Cap	$147M	$148M
Enterprise Value	$122M	$112M
Price	$10.16	$2.45
P/E Ratio	N/A	N/A
P/S Ratio	61.51x	4.30x
EV/Sales	51.05x	3.26x
EV/EBITDA	0.00x	8.61x
P/B Ratio	1.38x	1.01x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.78x	-0.92x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	143.63x	5.33x
Revenue & Growth
Revenue (TTM)	$2M	$34M
Revenue Growth (YoY)	-62.1%	-19.1%
Forward Rev Growth	240.0%	129.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-3068.6%	-329.0%
Net Margin (TTM)	-4477.1%	-312.6%
FCF Margin (TTM)	-2865.9%	-352.4%
Net Income (TTM)	$-107M	$-108M
FCF (TTM)	$-68M	$-121M
EPS (TTM)	-$6.05	-$1.78
ROE (TTM)	-11426.0%	-5792.0%
ROA (TTM)	-6857.0%	-4500.0%
ROIC (TTM)	-11426.0%	-5792.0%
Financial Health
Cash	$25M	$36M
Debt	$0	$0
Net Cash/Debt	$25M	$36M
Current Ratio (TTM)	9.55x	7.51x
Quick Ratio (TTM)	9.11x	7.16x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.27	1.11
52W Performance	-77.8%	-53.6%
YTD Performance	26.2%	-39.2%
% from 52W High	-81.8%	-55.9%
% from 52W Low	95.2%	5.2%
Efficiency & Yields
Asset Turnover (TTM)	0.04x	0.14x
FCF Yield (TTM)	-46.6%	-82.0%
Earnings Yield (TTM)	-72.8%	-72.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,927.9	-371.4
EV/GP/RG	N/A	N/A
Ticker research	View KRRO research	View VYGR research